About Takeda
- Headquartered in Tokyo, Japan
- Founded in 1781, incorporated in 1925
- R&D-driven global biopharmaceutical company
- Four therapeutic areas: oncology, gastroenterology (GI), rare diseases, and neuroscience
- Among the world’s largest pharmaceutical companies by both market capitalisation and sales
The worldwide integration of a strategic acquisition to harmonise business processes into a single way of working, powered by best-in-class technology across the enterprise.
In 2019, Takeda, a global pharmaceutical manufacturer, acquired global biotechnology firm Shire. The company engaged Deloitte in a multi-year business process redesign (BPR) programme to design and implement harmonised business processes with a common SAP® template as its backbone. Deloitte integrated 66 countries and 55,000 end users onto the platform, creating a “OneTakeda” working methodology. Finance, supply chain, commercial, and procurement methods are now standardised and in line with corporate policies; and the IT landscape has been streamlined and is ready for future data and digital initiatives.
- Harmonised legacy processes with the OneTakeda ways of working
- Data and processes harmonized across all Takeda entities
- Enabled Takeda Business Solutions to operate with the OneTakeda
- Simplified system landscape, reduced by half
- Best-in-class technology underpinned by a single and scalable ERP backbone
- A foundation for Takeda’s data and digital initiatives and journey to the cloud
- SAP®
- SAP® Ariba
- SAP® Concur
- SAP® IBP
- SAP® APO
- SAP® GTS
- Blackline
- SAP® Master Data Governance
- SAP® BW
- SAP® Analytics Cloud
“The Business Process Redesign Integration programme has harmonised legacy processes to our OneTakeda ways of working in just over two years. This is a remarkable achievement.”
— Rebecca Kaufmann, VP, Global Head of ERP Product Management
Opens in new window